The National Institute on Aging identified missing dementia subtype data as a key gap for family caregivers in 2026. Its March 17-19 virtual summit found that care, function and health records often cannot answer which type a person has.
AD/ADRD means Alzheimer's disease plus related dementias. That group includes frontotemporal degeneration, Lewy body dementia, vascular contributions to cognitive decline, and mixed-etiology dementia. Caregivers feel the gap when plans assume one cause and miss others.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which subtypes are missing from the data?
- Why do families and records disagree?
- Why is mixed dementia hard to pin down?
- What data barriers did NIA name?
- What can caregivers ask at the visit?
Which subtypes are missing from the data?
The National Institute on Aging defines AD/ADRD as Alzheimer's plus frontotemporal degeneration, Lewy body dementia, vascular contributions, and mixed-etiology dementias. Those subtypes share memory, thinking and behavior symptoms. Brain changes also overlap across types.
The 2026 NIH progress report on Alzheimer's and related dementias states that overlap makes differential diagnosis challenging. National Institute on Aging sources note most older adults with dementia have multiple pathologies at once. Mixed cases are therefore common in families but thin in records.
Why do families and records disagree?
A Yale cohort study of 3,278 adults with probable dementia found a wide disclosure gap. Among self-respondents with a Medicare-claims dementia diagnosis, 67% did not report being told they had dementia. The average for other conditions was 31%.
That finding matters for subtype care. A Yale cohort summary links the claims diagnosis to what patients say they heard. Families may manage medications, safety and driving without a clear shared label. Early-stage and mixed cases face the most confusion.
Why is mixed dementia hard to pin down?
A March 2026 Neurology study of confirmed Alzheimer's plus frontotemporal lobar degeneration found co-pathology is often overlooked in clinic. Brown University reporting described a second disorder hiding behind an Alzheimer's label. Care plans built on one diagnosis can miss movement, language or behavior needs.
Autopsy-validated research shows the same limit. Clinical Alzheimer's diagnosis had only 56.8% sensitivity at early dementia. Lewy-body diagnosis had about 20% predictive value. Subtype counts stay uncertain when tests, exams and pathology point in different directions.
What data barriers did NIA name?
The 2026 summit report says data silos and access barriers persist. National Institute on Aging summit participants called for infrastructure that makes caregiving, function and outcome data usable. McKnight's Senior Living reporting summarized the push for cooperative and national efforts.
NIA's Data LINKAGE program gives researchers virtual access linking surveys such as NHATS with CMS claims. That link supports study of functioning, caregiving and events like hip-fracture mortality. Participants also flagged access for early-stage researchers, harmonized rules across datasets, and patient privacy protection.
What can caregivers ask at the visit?
Ask for what is written, not only what was said. Records, surveys and claims often disagree in early-stage and mixed dementia. A short request list helps align the chart with daily care.
The MedlinePlus guide to dementia types plus the Yale finding support that practical step. MedlinePlus outlines types while the disclosure data show why written confirmation matters. Bring the list to each follow-up when symptoms or medications change.
- Ask for the documented subtype and what supports it
- Ask for disclosure notes showing what the patient was told
- Ask for the care plan tied to that subtype
You Might Also Like
- Privacy and Data Access Gaps in 2026 Dementia Research: A Source-Checked Research Briefing for Family Caregivers
- Young-Onset Dementia Cost Gaps Identified by NIA in 2026: What the Report Establishes and Leaves Unanswered for Working Dementia Caregivers
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: Study Design and Evidence Limits for People With Mild Cognitive Impairment
